Firsocostat

Generic Name: Firsocostat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₃₁N_₃O_₈S

CAS Number: 1434635-54-7

Unique Ingredient Identifier: XE10NJQ95M

Background: Firsocostat is under investigation in clinical trial NCT02781584 (Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication

DelveInsight's report on Nonalcoholic Steatohepatitis (NASH) provides insights into historical and forecasted epidemiology, market trends, current treatment practices, emerging drugs, and market size from 2019 to 2032 in the United States, EU5, and Japan. Key companies and therapies in the NASH market are highlighted, including recent developments like Aligos Therapeutics' Phase 1 data presentation.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy